The trademark PROTECTION was filed by Boehringer Ingelheim International GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 10, 2004, and received one opposition filed on August 10, 2004 by The Zockoll Group Limited on Likelihood of confusion. the opponent was represented by CSY LONDON and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 10, 2004
It was designated 'Basic Application' for International Application 0948505 at the World Intellectual Property Organization (WIPO).
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2006.The first Cancellation was filed by GlaxoSmithKline Biologicals S.A. (represented by ???) on April 15, 2009 and Final decision on costs – Request withdrawn.
The renewal of the trademark was recorded by the office on May 22, 2013.
Deletion of the representative of the trademark registration was recorded on October 25, 2006. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on September 22, 2008. Change of name and address of the trademark registration was recorded on June 22, 2009. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on June 28, 2010. Change of name and address of the trademark registration was recorded on February 21, 2018. Change of name and address of the trademark registration was recorded on March 4, 2021.
The Opposition with reference B 000719593 was rejected according to Article 8(1)(b) CTMR with decision issued on February 15, 2006 by the EUIPO.